Related Experiment Videos
Search for antiulcer agents at IDR
1Institute for Drug Research, Budapest, Hungary.
Die Pharmazie
|November 1, 2001
Summary
Researchers reviewed therapeutic agents for peptic ulcer treatment, detailing the creation of the omeprazole molecule. This work highlights advancements in drug discovery for gastrointestinal conditions.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Gastroenterology
Background:
- Peptic ulcers are a significant gastrointestinal condition requiring effective therapeutic agents.
- The Institute for Drug Research in Budapest has a history of developing novel pharmaceuticals.
Purpose of the Study:
- To review the development of therapeutic agents for peptic ulcer disease.
- To specifically describe the discovery and development process of the omeprazole molecule.
Main Methods:
- Literature review of research conducted at the Institute for Drug Research.
- Historical analysis of drug development pathways.
Main Results:
- The review covers various therapeutic agents developed for peptic ulcers.
- The genesis and key milestones in the development of omeprazole are elucidated.
Conclusions:
- The Institute for Drug Research has made substantial contributions to peptic ulcer treatment.
- The development of omeprazole exemplifies successful drug discovery and therapeutic innovation.